For what it’s worth

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

jbuffett62

Rank: Treasurer [?]

Points: 480 [?]

Votes: 13 Score: 2.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

For what it’s worth

posted on Jul 19, 2023 10:06AM

https://www.pharmaceutical-technology.com/data-insights/zen-3694-zenith-epigenetics-lung-cancer-likelihood-of-approval/

6 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply